Filing Details
- Accession Number:
- 0001209191-14-002781
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-01-10 15:50:59
- Reporting Period:
- 2014-01-08
- Filing Date:
- 2014-01-10
- Accepted Time:
- 2014-01-10 15:50:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1131324 | Genomic Health Inc | GHDX | Services-Medical Laboratories (8071) | 770552594 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1337798 | Bradley G Cole | 301 Penobscot Drive Redwood City CA 94063 | Coo | No | Yes | No | No |
Transaction Summary
| Sold: | 3,000 shares | Avg. Price: $28.17 | Total Value: $84,501.00 |
| Number of Shares After Transactions: | 18,369 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-01-08 | 3,000 | $2.88 | 21,369 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-01-08 | 3,000 | $28.17 | 18,369 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2014-01-08 | 3,000 | $2.88 | 3,000 | $2.88 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 14,337 | 2014-12-02 | No | 4 | M | Direct |
Footnotes
- These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on August 22, 2013.
- Represents weighted average sale price. Actual sale prices ranged from $27.95 to $28.53.
- Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- Includes 6,750 restricted stock units awarded on January 27, 2011, of which vest 1/3 of the shares vest on February 15, 2014, and 1/3 of the shares that vested on each of February 15, 2012 and 2013, net of withholding.
- Includes 6,700 restricted stock units awarded February 5, 2012, of which 1/3 vest on each of February 15, 2014 and 2015, and the 1/3 of the shares that vested on February 15, 2013, net of withholding.
- Includes 6,000 restricted stock units awarded July 25, 2013, of which 1/3 of the shares vest on each of February 15, 2014, 2015 and 2016.
- The option becomes exercisable as to 25% of the shares on December 2, 2005, and become exercisable as to 1/48th of the shares each full month thereafter.
Billionaire Hedge Funds
